Combination Therapy for the Pharmacological Management of Benign Prostatic Hyperplasia: Rationale and Treatment Options

ISSN： 1170-229X

Source： Drugs & Aging, Vol.22, Iss.11, 2005-01, pp. : 901-912

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Pharmacological Therapies for the Management of Benign Prostatic Hyperplasia

By Cohen Seth A. Parsons J. Kellogg

Drugs & Aging, Vol. 29, Iss. 4, 2012-04 ,pp. : 275-284

Adis International

Access to resources Recommend Favorite

Treatment options for benign prostatic hyperplasia

By Thurlow R.J.

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 225-246

Informa Healthcare

Access to resources Recommend Favorite

Current evidence supports the use of combination therapy in the management of benign prostatic hyperplasia

Drugs & Therapy Perspectives, Vol. 28, Iss. 12, 2012-12 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Treatment options for benign prostatic hyperplasia reviewed

Inpharma, Vol. 1, Iss. 1313, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1209-1211

Informa Healthcare

Access to resources Recommend Favorite